BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bester L, Meteling B, Pocock N, Pavlakis N, Chua TC, Saxena A, Morris DL. Radioembolization versus Standard Care of Hepatic Metastases: Comparative Retrospective Cohort Study of Survival Outcomes and Adverse Events in Salvage Patients. Journal of Vascular and Interventional Radiology 2012;23:96-105. [DOI: 10.1016/j.jvir.2011.09.028] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK. Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. Ann Surg Oncol. 2014;21:240-247. [PMID: 24114054 DOI: 10.1245/s10434-013-3300-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
2 Cho M, Gong J, Fakih M. The state of regional therapy in the management of metastatic colorectal cancer to the liver. Expert Rev Anticancer Ther 2016;16:229-45. [PMID: 26652741 DOI: 10.1586/14737140.2016.1129277] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
3 Tohme S, Sukato D, Nace GW, Zajko A, Amesur N, Orons P, Chalhoub D, Marsh JW, Geller DA, Tsung A. Survival and tolerability of liver radioembolization: a comparison of elderly and younger patients with metastatic colorectal cancer. HPB (Oxford) 2014;16:1110-6. [PMID: 25123597 DOI: 10.1111/hpb.12307] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
4 Seidensticker M, Powerski M, Seidensticker R, Damm R, Mohnike K, Garlipp B, Klopffleisch M, Amthauer H, Ricke J, Pech M. Cytokines and 90Y-Radioembolization: Relation to Liver Function and Overall Survival. Cardiovasc Intervent Radiol 2017;40:1185-95. [PMID: 28283704 DOI: 10.1007/s00270-017-1622-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
5 Reimer RP, Reimer P, Mahnken AH. Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis. Cardiovasc Intervent Radiol 2018;41:1545-56. [PMID: 29881933 DOI: 10.1007/s00270-018-2004-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
6 Brown D, Krebs H, Brower J, O'Hara R, Wang E, Vaheesan K, Du L, Matsuoka L, D'Souza D, Sze DY, Golzarian J, Gandhi R, Kennedy A. Incidence and risk factors for sustained hepatic function toxicity 6 months after radioembolization: analysis of the radiation-emitting sir-spheres in non-resectable liver tumor (RESIN) registry. J Gastrointest Oncol 2021;12:639-57. [PMID: 34012656 DOI: 10.21037/jgo-20-346] [Reference Citation Analysis]
7 Sotirchos VS, Petre EN, Brown KT, Brody LA, D'Angelica MI, DeMatteo RP, Kemeny NE, Sofocleous CT. Safe and Successful Yttrium-90 Resin Microsphere Radioembolization in a Heavily Pretreated Patient with Chemorefractory Colorectal Liver Metastases after Biliary Stent Placement above the Papilla. Case Reports Hepatol 2014;2014:921406. [PMID: 25580316 DOI: 10.1155/2014/921406] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
8 Sofocleous CT, Violari EG, Sotirchos VS, Shady W, Gonen M, Pandit-Taskar N, Petre EN, Brody LA, Alago W, Do RK, D'Angelica MI, Osborne JR, Segal NH, Carrasquillo JA, Kemeny NE. Radioembolization as a Salvage Therapy for Heavily Pretreated Patients With Colorectal Cancer Liver Metastases: Factors That Affect Outcomes. Clin Colorectal Cancer 2015;14:296-305. [PMID: 26277696 DOI: 10.1016/j.clcc.2015.06.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
9 Srinivas SM, Nasr EC, Kunam VK, Bullen JA, Purysko AS. Administered activity and outcomes of glass versus resin (90)Y microsphere radioembolization in patients with colorectal liver metastases. J Gastrointest Oncol 2016;7:530-9. [PMID: 27563442 DOI: 10.21037/jgo.2016.03.09] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 de Baere T, Tselikas L, Pearson E, Yevitch S, Boige V, Malka D, Ducreux M, Goere D, Elias D, Nguyen F, Deschamps F. Interventional oncology for liver and lung metastases from colorectal cancer: The current state of the art. Diagnostic and Interventional Imaging 2015;96:647-54. [DOI: 10.1016/j.diii.2015.04.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
11 Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA. Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus. J Gastrointest Oncol 2017;8:1079-99. [PMID: 29299370 DOI: 10.21037/jgo.2017.09.10] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kennedy A. Radioembolization of hepatic tumors. J Gastrointest Oncol. 2014;5:178-189. [PMID: 24982766 DOI: 10.3978/j.issn.2078-6891.2014.037] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
13 Reiner CS, Morsbach F, Sah BR, Puippe G, Schaefer N, Pfammatter T, Alkadhi H. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion. J Vasc Interv Radiol. 2014;25:747-759. [PMID: 24630751 DOI: 10.1016/j.jvir.2014.01.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
14 Kennedy AS, Ball D, Cohen SJ, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kanani S, Rose SC, Nutting CW, Moeslein FM, Savin MA, Schirm S, Putnam SG 3rd, Sharma NK, Wang EA. Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for (90)Y resin microspheres. J Gastrointest Oncol 2015;6:134-42. [PMID: 25830033 DOI: 10.3978/j.issn.2078-6891.2014.109] [Cited by in F6Publishing: 29] [Reference Citation Analysis]
15 O'Leary C, Greally M, McCaffrey J, Hughes P, Lawler LLP, O'Connell M, Geoghegan T, Farrelly C. Single-institution experience with selective internal radiation therapy (SIRT) for the treatment of unresectable colorectal liver metastases. Ir J Med Sci 2019;188:43-53. [PMID: 29511912 DOI: 10.1007/s11845-018-1773-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Tohme S, Sukato D, Chalhoub D, Mcdonald KACA, Zajko A, Amesur N, Orons P, Marsh JW, Geller DA, Tsung A. Neutrophil–Lymphocyte Ratio is a Simple and Novel Biomarker for Prediction of Survival after Radioembolization for Metastatic Colorectal Cancer. Ann Surg Oncol 2015;22:1701-7. [DOI: 10.1245/s10434-014-4050-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
17 Golfieri R, Mosconi C, Giampalma E, Cappelli A, Galaverni MC, Pettinato C, Renzulli M, Monari F, Mazzarotto R, Pinto C, Angelelli B. Selective transarterial radioembolisation of unresectable liver-dominant colorectal cancer refractory to chemotherapy. Radiol med 2015;120:767-76. [DOI: 10.1007/s11547-015-0504-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
18 Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Radioembolization-induced liver disease: a systematic review. European Journal of Gastroenterology & Hepatology 2017;29:144-52. [DOI: 10.1097/meg.0000000000000772] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 10.3] [Reference Citation Analysis]
19 Golfieri R. SIR-Spheres yttrium-90 radioembolization for the treatment of unresectable liver cancers. Hepat Oncol 2014;1:265-83. [PMID: 30190962 DOI: 10.2217/hep.14.6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
20 Sutphin PD, Ganguli S. Interventional Treatment of Hepatic Metastases from Colorectal Cancer. Semin Intervent Radiol 2020;37:492-8. [PMID: 33328705 DOI: 10.1055/s-0040-171919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Helmberger T, Arnold D, Bilbao JI, de Jong N, Maleux G, Nordlund A, Peynircioglu B, Sangro B, Sharma RA, Walk A. Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study. JMIR Res Protoc 2020;9:e16296. [PMID: 32319960 DOI: 10.2196/16296] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Gibbs P, Heinemann V, Sharma NK, Taieb J, Ricke J, Peeters M, Findlay M, Robinson B, Jackson C, Strickland A, Gebski V, Van Buskirk M, Zhao H, van Hazel G; SIRFLOX and FOXFIRE Global Trial Investigators. Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies. Clin Colorectal Cancer. 2018;17:e617-e629. [PMID: 30033117 DOI: 10.1016/j.clcc.2018.06.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
23 Brennan VK, Colaone F, Shergill S, Pollock RF. A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK. J Med Econ 2020;23:1588-97. [PMID: 33084466 DOI: 10.1080/13696998.2020.1839273] [Reference Citation Analysis]
24 Prince JF, van den Hoven AF, van den Bosch MA, Elschot M, de Jong HW, Lam MG. Radiation-Induced Cholecystitis after Hepatic Radioembolization: Do We Need to Take Precautionary Measures? Journal of Vascular and Interventional Radiology 2014;25:1717-23. [DOI: 10.1016/j.jvir.2014.06.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
25 Raval M, Bande D, Pillai AK, Blaszkowsky LS, Ganguli S, Beg MS, Kalva SP. Yttrium-90 radioembolization of hepatic metastases from colorectal cancer. Front Oncol. 2014;4:120. [PMID: 25120951 DOI: 10.3389/fonc.2014.00120] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
26 Türk G, Eldem G, Kılıçkap S, Bozkurt FM, Salancı BV, Çil BE, Peynircioğlu B, Yalçın Ş, Balkancı F. Outcomes of Radioembolization in Patients with Chemorefractory Colorectal Cancer Liver Metastasis: a Single-Center Experience. J Gastrointest Cancer 2019;50:236-43. [PMID: 29354877 DOI: 10.1007/s12029-018-0053-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Aranda E, Aparicio J, Bilbao JI, García-Alfonso P, Maurel J, Rodríguez J, Sangro B, Vieitez JM, Feliu J. Recommendations for SIR-Spheres Y-90 resin microspheres in chemotherapy-refractory/intolerant colorectal liver metastases. Future Oncol 2017;13:2065-82. [PMID: 28703622 DOI: 10.2217/fon-2017-0220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
28 Lee EW, Thakor AS, Tafti BA, Liu DM. Y90 Selective Internal Radiation Therapy. Surgical Oncology Clinics of North America 2015;24:167-85. [DOI: 10.1016/j.soc.2014.09.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
29 Bhooshan N, Sharma NK, Badiyan S, Kaiser A, Moeslein FM, Kwok Y, Amin PP, Kudryasheva S, Chuong MD. Pretreatment tumor volume as a prognostic factor in metastatic colorectal cancer treated with selective internal radiation to the liver using yttrium-90 resin microspheres. J Gastrointest Oncol 2016;7:931-7. [PMID: 28078116 DOI: 10.21037/jgo.2016.06.15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
30 Rosenbaum CE, van den Hoven AF, Braat MN, Koopman M, Lam MG, Zonnenberg BA, Verkooijen HM, van den Bosch MA. Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response. EJNMMI Res 2016;6:92. [PMID: 28004357 DOI: 10.1186/s13550-016-0236-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Buicko JL, Finnerty BM, Zhang T, Kim BJ, Fahey TJ, Nancy Du YC. Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors. Ann Pancreat Cancer. 2019;2. [PMID: 31535089 DOI: 10.21037/apc.2019.06.02] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Bester L, Meteling B, Pocock N, Saxena A, Chua TC, Morris DL. Radioembolisation with Yttrium-90 microspheres: an effective treatment modality for unresectable liver metastases. J Med Imaging Radiat Oncol. 2013;57:72-80. [PMID: 23374558 DOI: 10.1111/j.1754-9485.2012.02459.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
33 Karanicolas P, Beecroft JR, Cosby R, David E, Kalyvas M, Kennedy E, Sapisochin G, Wong R, Zbuk K; Gastrointestinal Disease Site Group. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline. Clin Colorectal Cancer 2021;20:20-8. [PMID: 33257278 DOI: 10.1016/j.clcc.2020.09.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Chao C, Stavropoulos SW, Mondschein JI, Dagli M, Sudheendra D, Nadolski G, Soulen MC. Effect of Substituting 50% Isovue for Sterile Water as the Delivery Medium for SIR-Spheres: Improved Dose Delivery and Decreased Incidence of Stasis. Clin Nucl Med 2017;42:176-9. [PMID: 28072623 DOI: 10.1097/RLU.0000000000001532] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
35 Turkmen C, Ucar A, Poyanli A, Vatankulu B, Ozkan G, Basaran M, Serin K, Sanli Y, Adalet I. Initial outcome after selective intraarterial radionuclide therapy with yttrium-90 microspheres as salvage therapy for unresectable metastatic liver disease. Cancer Biother Radiopharm 2013;28:534-40. [PMID: 23647219 DOI: 10.1089/cbr.2012.1455] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
36 Rosenbaum CE, Verkooijen HM, Lam MG, Smits ML, Koopman M, van Seeters T, Vermoolen MA, van den Bosch MA. Radioembolization for Treatment of Salvage Patients with Colorectal Cancer Liver Metastases: A Systematic Review. J Nucl Med 2013;54:1890-5. [DOI: 10.2967/jnumed.113.119545] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
37 Maleux G, Deroose C, Laenen A, Verslype C, Heye S, Haustermans K, De Hertogh G, Sagaert X, Topal B, Aerts R, Prenen H, Vanbeckevoort D, Vandecaveye V, Van Cutsem E. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival. Acta Oncol. 2016;55:486-495. [PMID: 26625262 DOI: 10.3109/0284186x.2015.1101151] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
38 Wang DS, Louie JD, Sze DY. Evidence-Based Integration of Yttrium-90 Radioembolization in the Contemporary Management of Hepatic Metastases from Colorectal Cancer. Techniques in Vascular and Interventional Radiology 2019;22:74-80. [DOI: 10.1053/j.tvir.2019.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Walter T, Hawkins NS, Pollock RF, Colaone F, Shergill S, Ross PJ. Systematic review and network meta-analyses of third-line treatments for metastatic colorectal cancer. J Cancer Res Clin Oncol 2020;146:2575-87. [PMID: 32715436 DOI: 10.1007/s00432-020-03315-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Rose SC, Kikolski SG, Chomas JE. Downstream Hepatic Arterial Blood Pressure Changes Caused by Deployment of the Surefire AntiReflux Expandable Tip. Cardiovasc Intervent Radiol 2013;36:1262-9. [DOI: 10.1007/s00270-012-0538-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
41 Theysohn JM, Müller S, Schlaak JF, Ertle J, Schlosser TW, Bockisch A, Lauenstein TC. Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery. Cardiovasc Intervent Radiol 2013;36:1015-22. [PMID: 22983697 DOI: 10.1007/s00270-012-0474-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
42 Marsala A, Lee EW, Padia SA. Yttrium-90 Radioembolization for Metastatic Colorectal Cancer: Outcomes by Number of Lines of Therapy. Semin Intervent Radiol 2017;34:116-20. [PMID: 28579679 DOI: 10.1055/s-0037-1602711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
43 Paprottka KJ, Lehner S, Fendler WP, Ilhan H, Rominger A, Sommer W, Clevert DA, Op den Winkel M, Heinemann V, Paprottka PM. Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres. J Nucl Med 2016;57:1679-84. [PMID: 27261516 DOI: 10.2967/jnumed.115.170779] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
44 Durack JC, Hope TA, Seo Y, Saeed M, He J, Wilson MW, Kerlan RK, Ring EJ. Intravenous Vasopressin for the Prevention of Nontarget Gastrointestinal Embolization during Liver-directed Cancer Treatment: Experimental Study in a Porcine Model. Journal of Vascular and Interventional Radiology 2012;23:1505-12. [DOI: 10.1016/j.jvir.2012.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
45 Fischman AM, Ward TJ, Patel RS, Arepally A, Kim E, Nowakowski FS, Lookstein RA. Prospective, Randomized Study of Coil Embolization versus Surefire Infusion System during Yttrium-90 Radioembolization with Resin Microspheres. Journal of Vascular and Interventional Radiology 2014;25:1709-16. [DOI: 10.1016/j.jvir.2014.08.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
46 White J, Carolan-Rees G, Dale M, Morgan HE, Patrick HE, See TC, Beeton EL, Swinson DEB, Bell JK, Manas DM, Crellin A, Slevin NJ, Sharma RA. Analysis of a National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases. Clin Oncol (R Coll Radiol). 2019;31:58-66. [PMID: 30297164 DOI: 10.1016/j.clon.2018.09.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
47 Kallini JR, Gabr A, Abouchaleh N, Ali R, Riaz A, Lewandowski RJ, Salem R. New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer. Cancer J 2016;22:373-80. [PMID: 27870679 DOI: 10.1097/PPO.0000000000000226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
48 Pardo F, Sangro B, Lee RC, Manas D, Jeyarajah R, Donckier V, Maleux G, Pinna AD, Bester L, Morris DL, Iannitti D, Chow PK, Stubbs R, Gow PJ, Masi G, Fisher KT, Lau WY, Kouladouros K, Katsanos G, Ercolani G, Rotellar F, Bilbao JI, Schoen M. The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres. Ann Surg Oncol. 2017;24:2465-2473. [PMID: 28653161 DOI: 10.1245/s10434-017-5950-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
49 Mayo SC, Herman JM, Cosgrove D, Bhagat N, Kamel I, Geschwind JF, Pawlik TM. Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies. J Am Coll Surg 2013;216:123-34. [PMID: 23063263 DOI: 10.1016/j.jamcollsurg.2012.08.027] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
50 de Baere T, Tselikas L, Yevich S, Boige V, Deschamps F, Ducreux M, Goere D, Nguyen F, Malka D. The role of image-guided therapy in the management of colorectal cancer metastatic disease. European Journal of Cancer 2017;75:231-42. [DOI: 10.1016/j.ejca.2017.01.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
51 Wang DS, Louie JD, Sze DY. Intra-arterial therapies for metastatic colorectal cancer. Semin Intervent Radiol. 2013;30:12-20. [PMID: 24436513 DOI: 10.1055/s-0033-1333649] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
52 Bester L, Feitelson S, Milner B, Chua TC, Morris DL. Impact of Prior Hepatectomy on the Safety and Efficacy of Radioembolization With Yttrium-90 Microspheres for Patients With Unresectable Liver Tumors. American Journal of Clinical Oncology 2014;37:454-60. [DOI: 10.1097/coc.0b013e31827deea1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
53 Parakh S, Gananadha S, Allen R, Yip D. Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings. Asian Journal of Surgery 2016;39:144-8. [DOI: 10.1016/j.asjsur.2015.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
54 Sangha BS, Nimeiri H, Hickey R, Salem R, Lewandowski RJ. Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial? Curr Treat Options Oncol 2016;17:26. [PMID: 27098532 DOI: 10.1007/s11864-016-0402-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
55 Bas A, Samanci C, Gulsen F, Cantasdemir M, Kabasakal L, Kantarci F, Numan F. Evaluation of Liver Stiffness After Radioembolization by Real-Time ShearWave™ Elastography: Preliminary Study. Cardiovasc Intervent Radiol 2015;38:957-63. [PMID: 25413262 DOI: 10.1007/s00270-014-1021-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Dendy MS, Ludwig JM, Kim HS. Predictors and prognosticators for survival with Yttrium-90 radioembolization therapy for unresectable colorectal cancer liver metastasis. Oncotarget 2017;8:37912-22. [PMID: 28415671 DOI: 10.18632/oncotarget.16007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
57 Siman W, Mawlawi OR, Mourtada F, Kappadath SC. Systematic and random errors of PET‐based 90 Y 3D dose quantification. Med Phys 2020;47:2441-9. [DOI: 10.1002/mp.14117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Sangro B, Martínez-urbistondo D, Bester L, Bilbao JI, Coldwell DM, Flamen P, Kennedy A, Ricke J, Sharma RA. Prevention and treatment of complications of selective internal radiation therapy: Expert guidance and systematic review: Sangro et al. Hepatology 2017;66:969-82. [DOI: 10.1002/hep.29207] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 12.8] [Reference Citation Analysis]
59 Phelip JM, Tougeron D, Léonard D, Benhaim L, Desolneux G, Dupré A, Michel P, Penna C, Tournigand C, Louvet C, Christou N, Chevallier P, Dohan A, Rousseaux B, Bouché O. Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR). Dig Liver Dis 2019;51:1357-63. [PMID: 31320305 DOI: 10.1016/j.dld.2019.05.035] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 17.0] [Reference Citation Analysis]
60 Mühlberg A, Holch JW, Heinemann V, Huber T, Moltz J, Maurus S, Jäger N, Liu L, Froelich MF, Katzmann A, Gresser E, Taubmann O, Sühling M, Nörenberg D. The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer. Eur Radiol 2021;31:834-46. [PMID: 32851450 DOI: 10.1007/s00330-020-07192-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Gibbs P, Gebski V, Van Buskirk M, Thurston K, Cade DN, Van Hazel GA. Selective Internal Radiation Therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study. BMC Cancer. 2014;14:897. [PMID: 25487708 DOI: 10.1186/1471-2407-14-897] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
62 Rosenbaum CE, van den Bosch MA, Veldhuis WB, Huijbregts JE, Koopman M, Lam MG. Added value of FDG-PET imaging in the diagnostic workup for yttrium-90 radioembolisation in patients with colorectal cancer liver metastases. Eur Radiol 2013;23:931-7. [PMID: 23111818 DOI: 10.1007/s00330-012-2693-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
63 Elsayed M, Martin JG, Dabrowiecki A, Goldman DT, Faraj R, McMahon JT, Kokabi N, Duszak R Jr, Newsome J, Bercu ZL. Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies. Nucl Med Commun 2019;40:1154-7. [PMID: 31568192 DOI: 10.1097/MNM.0000000000001089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
64 Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol. 2014;5:374-387. [PMID: 25276410 DOI: 10.3978/j.issn.2078-6891.2014.064] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
65 Elsayed M, Ermentrout RM, Sethi I, Bercu ZL, Galt JR, Whitmore M, Brandon DC, Schuster DM, Kokabi N. Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center. Clin Nucl Med 2020;45:100-4. [PMID: 31876805 DOI: 10.1097/RLU.0000000000002828] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
66 Jia Z, Paz-Fumagalli R, Frey GT, Sella DM, McKinney JM, Wang W. Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases. Expert Rev Gastroenterol Hepatol 2019;13:899-905. [PMID: 31104533 DOI: 10.1080/17474124.2019.1621166] [Reference Citation Analysis]
67 Uhlig J, Lukovic J, Dawson LA, Patel RA, Cavnar MJ, Kim HS. Locoregional Therapies for Colorectal Cancer Liver Metastases: Options Beyond Resection. Am Soc Clin Oncol Educ Book 2021;41:133-46. [PMID: 34010047 DOI: 10.1200/EDBK_320519] [Reference Citation Analysis]
68 Young S, Taylor A, Golzarian J, Flanagan S, D'souza D, Sanghvi T. Clinical utility of one month imaging following selective internal radiation therapy. Diagnostic and Interventional Imaging 2019;100:39-46. [DOI: 10.1016/j.diii.2018.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Siman W, Mikell JK, Mawlawi OR, Mourtada F, Kappadath SC. Dose volume histogram-based optimization of image reconstruction parameters for quantitative 90 Y-PET imaging. Med Phys 2019;46:229-37. [PMID: 30375655 DOI: 10.1002/mp.13269] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
70 Sofocleous CT, Garcia AR, Pandit-taskar N, Do KG, Brody LA, Petre EN, Capanu M, Longing AP, Chou JF, Carrasquillo JA, Kemeny NE. Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy. Clinical Colorectal Cancer 2014;13:27-36. [DOI: 10.1016/j.clcc.2013.11.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
71 Justinger C, Gruden J, Kouladouros K, Stravodimos C, Reimer P, Tannapfel A, Binnenhei M, Bentz M, Tatsch K, Rüdiger T, Schön MR. Histopathological changes resulting from selective internal radiotherapy (SIRT). J Surg Oncol 2018;117:1084-91. [DOI: 10.1002/jso.24967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
72 Bhat AP, Schuchardt PA, Bhat R, Davis RM, Singh S. Metastatic appendiceal cancer treated with Yttrium 90 radioembolization and systemic chemotherapy: A case report. World J Radiol 2019; 11(9): 116-125 [PMID: 31608143 DOI: 10.4329/wjr.v11.i9.116] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
73 Shamimi-Noori S, Gonsalves CF, Shaw CM. Metastatic Liver Disease: Indications for Locoregional Therapy and Supporting Data.Semin Intervent Radiol. 2017;34:145-166. [PMID: 28579683 DOI: 10.1055/s-0037-1602712] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
74 Pieper CC, Meyer C, Wilhelm KE, Block W, Nadal J, Ahmadzadehfar H, Willinek WA, Schild HH. Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience. J Vasc Interv Radiol. 2016;27:1305-1315. [PMID: 27461588 DOI: 10.1016/j.jvir.2016.05.028] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
75 Morshedi MM, Bauman M, Rose SC, Kikolski SG. Yttrium-90 Resin Microsphere Radioembolization Using an Antireflux Catheter: An Alternative to Traditional Coil Embolization for Nontarget Protection. Cardiovasc Intervent Radiol 2015;38:381-8. [DOI: 10.1007/s00270-014-0941-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]